SMS Pharmaceuticals Limited Financial Overview
SMS Pharmaceuticals Limited's market cap is currently ₹29.73B. The company's EPS TTM is ₹2.84; its P/E ratio is 33.07; and it has a dividend yield of 0.13%. SMS Pharmaceuticals Limited is scheduled to report earnings on November 8, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
